drugset / Trial / NCT01415505
Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of nebivolol and valsartan given as a free tablet combination in patient with stage 1 or stage 2 essential hypertension.
Timeline
- Start
- 2011-08
- Primary completion
- 2013-01
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nebivolol | Other / unclassified | 20 mg | Oral |
| Subject | Valsartan | Small molecule | 320 mg | Oral |
| Background | Hydrochlorothiazide | Unknown | 12.5 mg | Oral |
| Background | Hydrochlorothiazide | Unknown | 25 mg | Oral |